About this trial
This is a randomized controlled trial that aims to compare the effectiveness of two psychological treatment approaches: the Attempted Suicide Short Intervention Program (ASSIP) and Acceptance and Commitment Therapy (ACT). The study seeks to determine which of these two methods is more effective in reducing suicidal ideation and mental pain in individuals who have recently attempted suicide.
In this study, 60 participants with a history of suicide attempts will be randomly assigned to three groups. One group will receive ASSIP in addition to treatment as usual (TAU), the second group will receive ACT alongside TAU, and the third group will be a control group receiving TAU only. The results will be assessed using the Beck Scale for Suicide Ideation (BSSI) and the Orbach \& Mikulincer Mental Pain Scale (OMMP) at three stages: pre-test, post-test, and follow-up.
The ultimate goal of this research is to provide valuable insights into the comparative effectiveness of ASSIP and ACT interventions for suicide attempters and to contribute to evidence-based suicide prevention strategies. The findings are expected to inform clinical practice and guide future research in this field.
Eligibility criteria
Qualifiers
Being 18 years of age or older
Having the ability to read and write
Providing informed consent to participate in the study
Having at least one suicide attempt in the past 4 months
Disqualifiers
Having a severe psychiatric or physical illness that interferes with the treatment process
Receiving concurrent structured psychological interventions (other than TAU) that may interfere with the study's treatment process.
Lack of informed consent to participate in the study
Substance abuse based on DSM-5 criteria
Trial design
Treatments tested in this trial
- Attempted Suicide Short Intervention Program (ASSIP)
- Acceptance and Commitment Therapy (ACT)
- Treatment as Usual (TAU)